Conference abstract
Comparative bioequivalence study of two Rivaroxaban formulations in Iranian healthy volunteers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is a factor Xa inhibitor whose potent anticoagulant and antithrombotic effects have been demonstrated. This study was designed to evaluate the pharmacokinetics of a new generic formulation of rivaroxaban compared with a brand in healthy Iranian volunteers. Twenty-eight healthy volunteers enrolled in this study. This study employed a randomized, single-dose, two-way crossover method using oral tablets of either Axabin® or Xarelto®, as the test drug and reference drug, respectively. Two tablets (2Ã?10 mg) were administered with 240 ml water. Blood samples were gathered at the following times: 0 hour (predose), and 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 24, and 30 hours after drug administration. To provide an accurate analysis, rivaroxaban plasma concentrations were determined by an UHPLC-MS/MS. The optimum separation was performed with a C18 column using acetonitrile and 10mM ammonium acetate (pH = 3, 70:30, v/v) as a mobile phase, at a flow rate of 0.3 ml/min. Precipitation of proteins was employed for extraction of rivaroxaban from the plasma samples. The quantification range for rivaroxaban was 2.5â??600 ng.ml-1. According to FDA guidelines, the bioequivalence assessmentâ??s acceptable range is 80â??125% at a 90% confidence interval (CI) for the mean ratios of test/ reference formulation of the pharmacokinetic parameters. The 90% CI of parameters were AUC0-30 (82.02â??98.31), AUC0-inf (82.4- 100.34), and Cmax (82.7â??104.49). Therefore, the results proved the claim that the two formulations of rivaroxaban are bioequivalent.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mohammad-Reza Rouini”
- BylineArticles whose byline prints “Adel Haghighi”
- BylineArticles whose byline prints “Maryam Dibaei”
- BylineArticles whose byline prints “Ali Akbar Golabchifar”
- BylineArticles whose byline prints “Kourosh Sadeghi”
- BylineArticles whose byline prints “Nader Pourghasem”